Focus Partners Advisor Solutions’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$532K Buy
1,375
+321
+30% +$119K ﹤0.01% 789
2026
Q1
$306K Sell
1,054
-2,634
-71% -$866K ﹤0.01% 967
2025
Q4
$1.29M Buy
3,688
+278
+8% +$93.9K 0.02% 425
2025
Q3
$1.05M Buy
3,410
+2,109
+162% +$656K 0.01% 500
2025
Q2
$504K Sell
1,301
-1,311
-50% -$527K 0.01% 669
2025
Q1
$1.14M Buy
2,612
+1,756
+205% +$705K 0.02% 348
2024
Q4
$316K Sell
856
-351
-29% -$147K 0.01% 593
2024
Q3
$628K Buy
1,207
+345
+40% +$184K 0.01% 392
2024
Q2
$467K Buy
862
+198
+30% +$105K 0.01% 387
2024
Q1
$345K Buy
+664
New +$330K 0.01% 429
2023
Q1
Sell
-414
Closed -$213K 365
2022
Q4
$213K Sell
414
-369
-47% -$187K 0.02% 314
2022
Q3
$356K Buy
783
+126
+19% +$60.3K 0.02% 272
2022
Q2
$318K Buy
657
+84
+15% +$41.6K 0.03% 250
2022
Q1
$281K Buy
+573
New +$262K 0.03% 255

Other funds holding ELV

Focus Partners Advisor Solutions's ELV Position: Q2 2026 in Review

Focus Partners Advisor Solutions increased its Elevance Health (ELV) stake by 30% in Q2 2026, buying an estimated $119K and bringing the position to 1,375 shares worth $532K. The position accounts for ﹤0.01% of the portfolio, ranked #789.

Focus Partners Advisor Solutions first reported a position in ELV in Q1 2022 and has held it in 14 quarters since. The position peaked at $1.29M in Q4 2025. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Focus Partners Advisor Solutions held 1,375 shares of Elevance Health worth $532K as of Q2 2026.
  • Focus Partners Advisor Solutions bought 321 Elevance Health shares in Q2 2026, an estimated $119K.
  • Elevance Health made up ﹤0.01% of Focus Partners Advisor Solutions's portfolio in Q2 2026, its #789 holding.
  • Focus Partners Advisor Solutions first reported a position in Elevance Health in Q1 2022 and has held it in 14 quarters since.
  • Focus Partners Advisor Solutions's Elevance Health position peaked at $1.29M in Q4 2025.
  • 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Focus Partners Advisor Solutions's 13F filing for Q2 2026, filed 6 Aug 2026.